These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 862658)

  • 21. Macrophages in resistance to rickettsial infection: macrophage activation in vitro for killing of Rickettsia tsutsugamushi.
    Nacy CA; Meltzer MS
    J Immunol; 1979 Dec; 123(6):2544-9. PubMed ID: 115917
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Xid mouse lymphocytes respond to TI-2 antigens when co-stimulated by TI-1 antigens or lymphokines.
    Couderc J; Février M; Duquenne C; Sourbier P; Liacopoulos P
    Immunology; 1987 May; 61(1):71-6. PubMed ID: 3294578
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Suppression of ACTH-induced steroidogenesis by supernatants from LPS-treated peritoneal exudate macrophages.
    Mathison JC; Schreiber RD; La Forest AC; Ulevitch RJ
    J Immunol; 1983 Jun; 130(6):2757-62. PubMed ID: 6304189
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Macrophages in resistance to rickettsial infections: characterization of lymphokines that induce rickettsiacidal activity in macrophages.
    Nacy CA; Leonard EJ; Meltzer MS
    J Immunol; 1981 Jan; 126(1):204-7. PubMed ID: 7005333
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sequential expression of functions during macrophage differentiation in murine bone marrow liquid cultures.
    Neumann C; Sorg C
    Eur J Immunol; 1980 Nov; 10(11):834-40. PubMed ID: 6161825
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sequential activation of murine mononuclear phagocytes for tumor cytolysis: differential expression of markers by macrophages in the several stages of development.
    Johnson WJ; Marino PA; Schreiber RD; Adams DO
    J Immunol; 1983 Aug; 131(2):1038-43. PubMed ID: 6306103
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Colony-stimulating factor (CSF-1): its enhancement of plasminogen activator production and inhibition of cell growth in a mouse macrophage cell line.
    Chen BD; Lin HS
    J Immunol; 1984 Jun; 132(6):2955-60. PubMed ID: 6327811
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasminogen activator is an apparent lymphocyte mitogen.
    Cohen SD; Israel E; Spiess-Meier B; Wainberg MA
    J Immunol; 1981 Apr; 126(4):1415-20. PubMed ID: 6259259
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Membranes from both Th1 and Th2 T cell clones stimulate B cell proliferation and prepare B cells for lymphokine-induced differentiation to secrete Ig.
    Hodgkin PD; Yamashita LC; Seymour B; Coffman RL; Kehry MR
    J Immunol; 1991 Dec; 147(11):3696-702. PubMed ID: 1834744
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation of pulmonary macrophages for fungicidal activity by gamma-interferon or lymphokines.
    Brummer E; Stevens DA
    Clin Exp Immunol; 1987 Dec; 70(3):520-8. PubMed ID: 3124995
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Macrophage activation for microbicidal activity against Leishmania major: inhibition of lymphokine activation by phosphatidylcholine-phosphatidylserine liposomes.
    Gilbreath MJ; Nacy CA; Hoover DL; Alving CR; Swartz GM; Meltzer MS
    J Immunol; 1985 May; 134(5):3420-5. PubMed ID: 3980997
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Secretion of plasminogen activator by bone marrow-derived mononuclear phagocytes and its enhancement by colony-stimulating factor.
    Lin HS; Gordon S
    J Exp Med; 1979 Aug; 150(2):231-45. PubMed ID: 313429
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mac-2, a novel 32,000 Mr mouse macrophage subpopulation-specific antigen defined by monoclonal antibodies.
    Ho MK; Springer TA
    J Immunol; 1982 Mar; 128(3):1221-8. PubMed ID: 6173426
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Similarities among factors that render macrophages tumoricidal in lymphokine and interferon preparations.
    Schultz RM; Chirigos MA
    Cancer Res; 1978 Apr; 38(4):1003-7. PubMed ID: 346202
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasminogen activator production by human monocytes. I. Enhancement by activated lymphocytes and lymphocyte products.
    Greineder DK; Connorton KJ; David JR
    J Immunol; 1979 Dec; 123(6):2808-13. PubMed ID: 501090
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Species-restricted effects of human and mouse lymphokines on macrophages.
    Tagliabue A; Mantovani A; Boraschi D; Herberman RB
    Eur J Immunol; 1980 Jul; 10(7):542-6. PubMed ID: 6157542
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inducible macrophage cytotoxins. I. Biokinetics of activation and release in vitro.
    Reidarson TH; Levy WE; Klostergaard J; Granger GA
    J Natl Cancer Inst; 1982 Oct; 69(4):879-87. PubMed ID: 6956764
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Macrophages as effector cells of protective immunity in murine schistosomiasis. VI. T cell-dependent, lymphokine-mediated, activation of macrophages in response to Schistosoma mansoni antigens.
    James SL; Lazdins JK; Hieny S; Natovitz P
    J Immunol; 1983 Sep; 131(3):1481-6. PubMed ID: 6350456
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Production of BSF-1 during an in vivo, T-dependent immune response.
    Finkelman FD; Ohara J; Goroff DK; Smith J; Villacreses N; Mond JJ; Paul WE
    J Immunol; 1986 Nov; 137(9):2878-85. PubMed ID: 3489779
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The production of fibrinolysis inhibitors as a parameter of the activation state in murine macrophages.
    Klimetzek V; Sorg C
    Eur J Immunol; 1979 Aug; 9(8):613-9. PubMed ID: 499330
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.